Somatic gene mutation and human disease other than cancer

被引:84
作者
Erickson, RP [1 ]
机构
[1] Univ Arizona, Coll Med,Angel Char Children Wing Genet Res, Dept Pediat & Mol & Cellular Biol, Sect Med & Mol Genet,Steele Mem Childrens Res Ctr, Tucson, AZ 85724 USA
关键词
mosaicism; revertants; skin manifestations; genetic syndromes;
D O I
10.1016/S1383-5742(03)00010-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
While the focus of much mutation research is on germ-line mutation, somatic mutation is being found to be important in human disease. Neurofibromatosis 1 and McCune-Albright are disorders which are detected in the skin and other systems. The skin manifestations were essential for the demonstration of somatic mosaicism in neurofibromatosis 1, while analysis of blood DNA demonstrated somatic mutation in neurcifibromatosis 2. Incontinentia pigmenti is also a disorder seen in skin and other tissues, but here it is the rare variant of the disorder in males, where it is usually lethal, that involves somatic mosaicism. Paroxysmal nocturnal hemoglobinuria is a disorder of the blood and cell separation of blood elements allows the demonstration of the somatic. mosaicism. This review also discusses disorders in which somatic mosaicism, for mutations probably incompatible with life if the mutation had been germ-line, are likely to be involved. These include the Proteus syndrome, which involves both vascular tissues and bones, and two disorders which might be thought of as representing two subtypes of Proteus: Klippel-Trenaunay, which involves vascular tissues, and Maffuci, which involves bones. Embryonic mutations, which create mosaicism for both the soma and germ-line, are being increasingly found in a number of disorders and are discussed more briefly. Finally, reverse mutations involving the soma have been recently found in several disorders and such revertant mutations are also examined. While the review focuses on the clinical importance of somatic mutations, many of the mutations found to date are tabulated. It is too early to see if there is a different pattern of somatic mutation as compared to germ-line mutation. Although the parameters to allow careful quantitation are not yet available, it seems that the frequency of gene mutation in embryonic cells is not markedly different than that in the germ-line.. (C) 2003 Published by Elsevier Science B.V.
引用
收藏
页码:125 / 136
页数:12
相关论文
共 114 条
  • [1] Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females - Report of five cases
    Albright, F
    Butler, AM
    Hampton, AO
    Smith, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1937, 216 : 727 - 746
  • [2] Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and a gonadal dysfunction - Further observations including the report of two more cases
    Albright, F
    Scoville, B
    Sulkowitch, HW
    [J]. ENDOCRINOLOGY, 1938, 22 (04) : 411 - 421
  • [3] AO AM, 2000, FERTIL STERIL, V74, pS173
  • [4] Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
    Araten, DJ
    Nafa, K
    Pakdeesuwan, K
    Luzzatto, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) : 5209 - 5214
  • [5] THE ETIOLOGY OF THE KLIPPEL-TRENAUNAY SYNDROME
    BASKERVILLE, PA
    ACKROYD, JS
    BROWSE, NL
    [J]. ANNALS OF SURGERY, 1985, 202 (05) : 624 - 627
  • [6] Becker J, 1996, AM J HUM GENET, V58, P657
  • [7] Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone
    Bianco, P
    Riminucci, M
    Majolagbe, A
    Kuznetsov, SA
    Collins, MT
    Mankani, MH
    Corsi, A
    Bone, HG
    Wientroub, S
    Spiegel, AM
    Fisher, LW
    Robey, PG
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) : 120 - 128
  • [8] Biesecker LG, 1998, AM J MED GENET, V79, P311, DOI 10.1002/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO
  • [9] 2-U
  • [10] Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO